Oral Polio Vaccine to Mitigate the Risk of Illness and Mortality During the Coronavirus Disease 2019 Pandemic: A Cluster-Randomized Trial in Guinea-Bissau

BACKGROUND: Oral polio vaccine (OPV) may improve resistance to non-polio-infections. We tested whether OPV reduced the risk of illness and mortality before coronavirus disease 2019 (COVID-19) vaccines were available. METHODS: During the early COVID-19 pandemic, houses in urban Guinea-Bissau were ran...

Descripción completa

Detalles Bibliográficos
Autores principales: Fisker, Ane B, Martins, Justiniano S D, Nanque, Line M, Jensen, Andreas M, Ca, Elsi J C, Nielsen, Sebastian, Martins, Cesario L, Rodrigues, Amabelia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9494416/
https://www.ncbi.nlm.nih.gov/pubmed/36193229
http://dx.doi.org/10.1093/ofid/ofac470

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9494416/
https://www.ncbi.nlm.nih.gov/pubmed/36193229
http://dx.doi.org/10.1093/ofid/ofac470

Ejemplares similares